Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI119713

Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.

L De Franceschi, D Bachir, F Galacteros, G Tchernia, T Cynober, S Alper, O Platt, Y Beuzard, and C Brugnara

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by De Franceschi, L. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by Bachir, D. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by Galacteros, F. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by Tchernia, G. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by Cynober, T. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by Alper, S. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by Platt, O. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by Beuzard, Y. in: JCI | PubMed | Google Scholar

Department of Medicine, University of Verona, Verona, 37134 Italy.

Find articles by Brugnara, C. in: JCI | PubMed | Google Scholar

Published October 1, 1997 - More info

Published in Volume 100, Issue 7 on October 1, 1997
J Clin Invest. 1997;100(7):1847–1852. https://doi.org/10.1172/JCI119713.
© 1997 The American Society for Clinical Investigation
Published October 1, 1997 - Version history
View PDF
Abstract

Intracellular polymerization and sickling depend markedly on the cellular concentration of sickle hemoglobin (Hb S). A possible therapeutic strategy for sickle cell disease is based on reducing the cellular concentration of Hb S through prevention of erythrocyte dehydration. The K-Cl cotransporter is a major determinant of sickle cell dehydration and is inhibited by increasing erythrocyte Mg content. We studied 10 patients with sickle cell disease before treatment and after 2 and 4 wk of treatment with oral Mg supplements (0.6 meq/kg/d Mg pidolate). Hematological parameters, erythrocyte Na, K, and Mg content, erythrocyte density, membrane transport of Na and K, and osmotic gradient ektacytometry were measured. We found significant increases in sickle erythrocyte Mg and K content and reduction in the number of dense sickle erythrocytes. Erythrocyte K-Cl cotransport was reduced significantly. We also observed a significant reduction in the absolute reticulocyte count and in the number of immature reticulocytes. Ektacytometric analysis showed changes indicative of improved hydration of the erythrocytes. There were no laboratory or clinical signs of hypermagnesemia. Mild, transient diarrhea was the only reported side effect. We conclude that oral Mg supplementation reduces the number of dense erythrocytes and improves the erythrocyte membrane transport abnormalities of patients with sickle cell disease.

Version history
  • Version 1 (October 1, 1997): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts